Literature DB >> 23080483

The reliability, validity, and applicability of an English language version of the Mini-ICF-APP.

Andrew Molodynski1, Michael Linden, George Juckel, Ksenija Yeeles, Catriona Anderson, Maria Vazquez-Montes, Tom Burns.   

Abstract

PURPOSE: This study aimed at establishing the validity and reliability of an English language version of the Mini-ICF-APP.
METHODS: One hundred and five patients under the care of secondary mental health care services were assessed using the Mini-ICF-APP and several well-established measures of functioning and symptom severity. 47 (45 %) patients were interviewed on two occasions to ascertain test-retest reliability and 50 (48 %) were interviewed by two researchers simultaneously to determine the instrument's inter-rater reliability. Occupational and sick leave status were also recorded to assess construct validity.
RESULTS: The Mini-ICF-APP was found to have substantial internal consistency (Chronbach's α 0.869-0.912) and all 13 items correlated highly with the total score. Analysis also showed that the Mini-ICF-APP had good test-retest (ICC 0.832) and inter-rater (ICC 0.886) reliability. No statistically significant association with length of sick leave was found, but the unemployed scored higher on the Mini ICF-APP than those in employment (mean 18.4, SD 9.1 vs. 9.4, SD 6.4, p < 0.001). The Mini-ICF-APP correlated highly with the other measures of illness severity and functioning considered in the study.
CONCLUSIONS: The English version of the Mini-ICF-APP is a reliable and valid measure of disorders of capacity as defined by the International Classification of Functioning. Further work is necessary to establish whether the scale could be divided into sub scales which would allow the instrument to more sensitively measure an individual's specific impairments.

Entities:  

Mesh:

Year:  2012        PMID: 23080483     DOI: 10.1007/s00127-012-0604-8

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  21 in total

1.  Mental disorders: employment and work productivity in Singapore.

Authors:  Siow Ann Chong; Janhavi Ajit Vaingankar; Edimansyah Abdin; Mythily Subramaniam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-06-03       Impact factor: 4.328

Review 2.  Revising axis V for DSM-IV: a review of measures of social functioning.

Authors:  H H Goldman; A E Skodol; T R Lave
Journal:  Am J Psychiatry       Date:  1992-09       Impact factor: 18.112

Review 3.  Social functioning as an outcome measure in schizophrenia studies.

Authors:  T Burns; D Patrick
Journal:  Acta Psychiatr Scand       Date:  2007-10-17       Impact factor: 6.392

4.  Objective social outcomes index (SIX): a method to summarise objective indicators of social outcomes in mental health care.

Authors:  S Priebe; S Watzke; L Hansson; T Burns
Journal:  Acta Psychiatr Scand       Date:  2008-07       Impact factor: 6.392

5.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  The Groningen Social Disabilities Schedule: development, relationship with I.C.I.D.H., and psychometric properties.

Authors:  D Wiersma; A DeJong; J Ormel
Journal:  Int J Rehabil Res       Date:  1988       Impact factor: 1.479

Review 8.  Symptom rating scales and outcome in schizophrenia.

Authors:  Ann M Mortimer
Journal:  Br J Psychiatry Suppl       Date:  2007-08

9.  Disorders of functions and disorders of capacity in relation to sick leave in mental disorders.

Authors:  S Baron; M Linden
Journal:  Int J Soc Psychiatry       Date:  2009-01

10.  The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial.

Authors:  Tom Burns; Jocelyn Catty; Thomas Becker; Robert E Drake; Angelo Fioritti; Martin Knapp; Christoph Lauber; Wulf Rössler; Toma Tomov; Jooske van Busschbach; Sarah White; Durk Wiersma
Journal:  Lancet       Date:  2007-09-29       Impact factor: 79.321

View more
  20 in total

1.  Different work capacity impairments in patients with different work-anxieties.

Authors:  Beate Muschalla
Journal:  Int Arch Occup Environ Health       Date:  2015-10-29       Impact factor: 3.015

2.  [Assement of incapacity to work and the Mini-ICF-APP].

Authors:  Benedikt Habermeyer; Stefan Kaiser; Wolfram Kawohl; Erich Seifritz
Journal:  Neuropsychiatr       Date:  2017-08-30

3.  The effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole.

Authors:  Andreas Schreiner; Paul Bergmans; Pierre Cherubin; Ludger Hargarter
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-14

4.  Development and Construct Validity of the Work Instability Scale for People With Common Mental Disorders in a Sample of Depressed and Anxious Workers: A Rasch Analysis.

Authors:  Louise Danielsson; Robin Fornazar; Kristina Holmgren; Åsa Lundgren Nilsson; Gunnel Hensing
Journal:  Rehabil Process Outcome       Date:  2020-07-14

5.  Patients Characteristics and Psychosocial Treatment in Psychodynamic and Cognitive Behavior Therapy.

Authors:  Beate Muschalla; Michael Linden; Matthias Rose
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

6.  Students or medical professionals: whose knowledge improved after social-medicine training? Results from a quasi-experimental evaluation study.

Authors:  Beate Muschalla; Stefanie Baron; Theresa Klevers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-01-05       Impact factor: 4.519

7.  Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics.

Authors:  A Schreiner; P Bergmans; P Cherubin; S Keim; P-M Llorca; B Cosar; A Petralia; G Corrivetti; L Hargarter
Journal:  J Psychopharmacol       Date:  2015-05-21       Impact factor: 4.153

8.  Use of a structured functional evaluation process for independent medical evaluations of claimants presenting with disabling mental illness: rationale and design for a multi-center reliability study.

Authors:  Monica Bachmann; Wout de Boer; Stefan Schandelmaier; Andrea Leibold; Renato Marelli; Joerg Jeger; Ulrike Hoffmann-Richter; Ralph Mager; Heinz Schaad; Thomas Zumbrunn; Nicole Vogel; Oskar Bänziger; Jason W Busse; Katrin Fischer; Regina Kunz
Journal:  BMC Psychiatry       Date:  2016-07-29       Impact factor: 3.630

9.  Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy.

Authors:  Federica Pinna; Andrea Fiorillo; Massimo Tusconi; Beatrice Guiso; Bernardo Carpiniello
Journal:  Int J Ment Health Syst       Date:  2015-10-31

10.  Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia.

Authors:  L Hargarter; P Bergmans; P Cherubin; S Keim; A Conca; A Serrano-Blanco; I Bitter; N Bilanakis; A Schreiner
Journal:  Expert Opin Pharmacother       Date:  2016-05-09       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.